Haemophilia A

HZRM Haemophilie-Zentrum Rhein Main GmbH in Frankfurt focuses on clinical research in Haemophilia A, with particular attention to patients affected by factor VIII inhibitors and the management of difficult-to-treat bleeding disorders.

• Inhibitor-related haemophilia care
• Immune tolerance induction
• Factor VIII recovery
• Factor VIII half-life
• Bleeding control

The sponsor’s active research interest centres on treatment outcomes in patients with persistent inhibitors and on clinical measures linked to coagulation factor replacement and bleeding burden.